Do you have Atopic Dermatitis?
Atopic dermatitis (AD), the most common form of eczema, is a chronic inflammatory skin disorder that affects individuals of all ages, ethnicities, and geographic regions worldwide.
We are currently recruiting subjects aged 18 to 70 years with moderate to severe Atopic Dermatitis (Eczema) to take part in a research study.
Compensation for time and travel may be available. There will be no cost to you for being considered or for taking part in this study, and you will be provided with all study medication, examinations, and medical care related to the study.
Join the trial to contribute to the development of this treatment and potentially benefit from its effects.
Visits
Total
Length
Procedures
Study Length
Total
18 visits over approximately 9 months
Length
2 to 4 hours
Procedures
Blood samples will be collected from all participants
Study Length
Up to 4 weeks of screening period 24 weeks of treatment and approximately 12 weeks of follow up period
Summary
This study is being done to evaluate how safe, effective, and tolerable the study drug is. The study drug is an injectable (like a shot) investigational medication known as ATI-045.
